
Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more
The latest news for pharma industry insiders.
Advancements in periodontal disease could make way for expansions in the dental space and other medical fields.
Jeffrey Goad discusses key considerations for travelers regarding medications, maintaining medication schedules across time zones, ensuring proper vaccinations, and the importance of consulting health care professionals before international trips.
Critical infrastructure operators say the proposed regulation is confusing and burdensome.
IQVIA™ announced that Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness.
A new analysis of insurance claims data showed that 85% of people who newly started taking drugs like Ozempic were no longer taking them 2 years later, and 71% of people stopped taking them within 1 year.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.